https://www.statnews.com/2025/07/17/blenrep-advisory-committee-fda-gsk-multiple-myeloma/
0
0
7/17/25 at 5:59pm
Organization
STAT
Author
Andrew Joseph
FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the selected dose
Create an account
or login to join the discussion